000 03775naa a22006257i 4500
001 UMUN-OA-20261005-PH-027
003 local
005 20261005174913.0
006 m o d
007 cr||||||||||||
008 261005s2022 xx o u000 0 eng d
024 7 _a10.3390/cancers14071732
_2doi
035 _a(local)EuropePMC:PMC8996939
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aMd Sanower Hossain
_eauthor.
245 1 0 _aColorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. /
_cMd Sanower Hossain; Hidayah Karuniawati; Ammar Abdulrahman Jairoun [and others].
264 1 _a[Place of publication not identified] :
_bMultidisciplinary Digital Publishing Institute (MDPI),
_c2022.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aColorectal cancer (CRC) is the second most deadly cancer. Global incidence and mortality are likely to be increased in the coming decades. Although the deaths associated with CRC are very high in high-income countries, the incidence and fatalities related to CRC are growing in developing countries too. CRC detected early is entirely curable by surgery and subsequent medications. However, the recurrence rate is high, and cancer drug resistance increases the treatment failure rate. Access to early diagnosis and treatment of CRC for survival is somewhat possible in developed countries. However, these facilities are rarely available in developing countries. Highlighting the current status of CRC, its development, risk factors, and management is crucial in creating public awareness. Therefore, in this review, we have comprehensively discussed the current global epidemiology, drug resistance, challenges, risk factors, and preventive and treatment strategies of CRC. Additionally, there is a brief discussion on the CRC development pathways and recommendations for preventing and treating CRC.
540 _aCreative Commons Attribution. See the linked licence for the applicable terms.
_uhttps://creativecommons.org/licenses/by/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Public Health.
650 4 _aDrug resistance
650 4 _aPrevalence
650 4 _aColon cancer
650 4 _aRectum cancer
650 4 _aAnus Cancer
653 _aB. Sc. Public Health
653 _aUMUN open access collection
653 _aepidemiology
655 4 _aReview articles.
700 0 _aHidayah Karuniawati
_eauthor.
700 0 _aAmmar Abdulrahman Jairoun
_eauthor.
700 0 _aZannat Urbi
_eauthor.
700 0 _aDer Jiun Ooi
_eauthor.
700 0 _aAkbar John
_eauthor.
700 0 _aYa Chee Lim
_eauthor.
700 0 _aK M Kaderi Kibria
_eauthor.
700 0 _aA K M Mohiuddin
_eauthor.
700 0 _aLong Chiau Ming
_eauthor.
700 0 _aKhang Wen Goh
_eauthor.
700 0 _aMuhammad Abdul Hadi
_eauthor.
773 0 _tCancers
_gVol. 14, no. 7, (2022), pages/article 1732
_x2072-6694
856 4 0 _uhttps://europepmc.org/articles/PMC8996939
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC8996939
_qlocal
942 _n0
999 _c1299
_d1299